So who’s more important: the drug users or the drug dealers?

28 Comments

Following up on the whole discipline angle from the last post, it definitely seems like more is going to happen before there is either any legal action or baseball disciplinary action in the A-Rod case. I mean, last I checked we don’t prosecute people based on newspaper articles alone.

But what that next step is will be extremely interesting. Because it will tell us whether Major League Baseball and the DEA is more interested in drug users or drug dealers.

Back in the Mitchell Report days, MLB, George Mitchell and federal agents went to the drug dealers first and gave them various degrees of immunity. Why? Because no one cared about drug dealers. The Mitchell Report, as I wrote at length back in the day, was a public relations exercise and everyone involved wanted to get the names of PED-using players out in the open. The league wanted to look like it was taking action, George Mitchell wanted prestige and billable hours for his law firm and the feds wanted some big, celebrity heads on pikes.  This, by the way, is a lot of the reason why the lowest hanging fruit was picked back then and guys like A-Rod and Biogenesis went unmentioned.

But what now?  Once again we have MLB and the DEA pursuing PEDs. Based on the Miami New Times report, the next obvious move for law enforcement is to either get players like A-Rod, Nelson Cruz, Bartolo Colon, Gio Gonzalez and others in a room to talk about the clinic’s possibly illegal prescriptions or else to get the clinic’s operators in to talk about the users. That’s how the next phase of this has to go.

Will the DEA decide to pursue distributors or end users? Will MLB seek out the quickest means to get “just cause” suspension evidence on the players, or will it attempt to learn everything it can about what may very well be the biggest pipeline of drugs into its sport?

The choices that are made about all of this in the coming days will tell us a lot about the league’s and the feds’ priorities.

Phillies, RHP Taijuan Walker reportedly agree to 4-year deal

Kyle Ross-USA TODAY Sports
0 Comments

SAN DIEGO – The active Philadelphia Phillies added Taijuan Walker to their rotation on Tuesday, agreeing to a $72 million, four-year contract with the right-hander.

A person familiar with the negotiations confirmed the move to The Associated Press on condition of anonymity because it was pending a physical.

It was the second major free-agent score for the Phillies at the winter meetings after they reeled in shortstop Trea Turner on Monday with a $300 million, 11-year deal. Walker and Turner join a Phillies team that made it to the World Series this year before losing to the Houston Astros.

The 30-year-old Walker went 12-5 with a 3.49 ERA in 29 starts this season for the New York Mets, one of Philadelphia’s biggest NL East rivals. He slots into a rotation fronted by Zack Wheeler and Aaron Nola.

The Phillies recently lost pitcher Zach Eflin in free agency to Tampa Bay.

Asked about the market for Walker earlier in the day, agent Scott Boras said it was robust.

“As you can see in the marketplace, there’s a whole number of pitchers that are throwing 60 and 70 innings that have been pursued, probably with the exception of (Jacob) deGrom, at the lower end of threshold around $13-15 million a year because the demand for quality pitching is so great,” Boras said.

“So, Tai … is one of the younger ones, one of the more durable ones and we expect him to be pursued greatly as his market unfolds.”

Walker was selected by Seattle with the No. 43 pick in the 2010 amateur draft. He made his big league debut with the Mariners in 2013.

Walker signed with New York as a free agent in February 2021. He turned down a $7.5 million player option last month in favor of a $3 million buyout, making his deal worth $17 million over two seasons.

The 6-foot-4 Walker made the All-Star team for the first time in 2021, putting together a fast start before fading to a 7-11 record with a 4.47 ERA in 30 games, 29 starts.